Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC Meeting Abstract
| Authors: | Rudin, C. M.; Kim, H. R.; Navarro, A.; Gottfried, M.; Peters, S.; Csoszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Yang, J. C. H.; Mazieres, J.; Kato, T.; Kalemkerian, G. P.; Dettman, E.; Edmondson, M.; Vajdi, A.; Loboda, A.; El-Osta, H. E.; Zhao, B.; Awad, M. M. |
| Abstract Title: | Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.8503 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 8503 -- Meeting also presented virtually -- Source: Cinahl |
